Spectral Medical (TSE:EDT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Spectral Medical Inc. has successfully closed an additional US$1 million offering of convertible notes to a major shareholder, bolstering the company’s financial position as it advances the Tigris trial for its PMX treatment for septic shock. The proceeds will support the ongoing Phase III trial and general corporate needs. This move reflects the shareholder’s confidence in the company during a critical phase of development.
For further insights into TSE:EDT stock, check out TipRanks’ Stock Analysis page.